Brandon Rapier

Sr. Territory Account Manager at Illumina

[Illumina @illumina]

Biology unfolds at the protein level.

The study of proteins — or proteomics — captures the real-time activity of proteins that drive health and disease. As part of an integrated multiomic approach, understanding proteomics helps connect genetic variation to functional biological outcomes.

Recent innovations are transforming proteomics from a targeted, low-throughput discipline into a scalable, high-throughput science that can be integrated with sequencing workflows.

Today, Illumina is unveiling the latest updates to our SOMAmer™ proteomics technologies, which are designed to measure biologically meaningful proteomic signals at scale using synthetic affinity reagents — engineered for specificity. Now supported by more than 1,500 peer-reviewed publications demonstrating real-world biological relevance, our SOMAmer technologies offer unparalleled scale and reproducibility.

[Illumina @illumina]

Every breakthrough in cancer research depends on critical cellular insights — and we're helping make them possible.

Stop by #AACR26, Booth 4727, to see our latest single-cell and multiomics methods in action, designed to accelerate discovery at every stage of cancer research, without specialized equipment.

Plus, don't miss our spotlight talk on April 19, where Richard Capper, David Spencer, and Claire Mills will explore multiomic liquid biopsy and spatial transcriptomics for next-generation cancer research: https://t.co/7rA6BaIEsn

[Illumina @illumina]

With DRAGEN v4.5, researchers can uncover more with every sequencing run.

Built for researchers in rare disease and precision oncology, v4.5 improves variant calling accuracy across challenging sample types and extends insights into difficult-to-map regions of the genome, delivering precision and scalability – even for some of the most ambitious research demands.

Explore what's new in DRAGEN v4.5: https://t.co/88H5Ur9MhV

#Genomics #RareDisease #Multiomics

[Illumina @illumina]

With TruPath™ Genome, we are getting closer to "one test fits all." At #ACMG2026, come see how we are driving long-range insights with short-read technology, and hear how TruPath™ is helping KOLs drive crucial new insights for rare disease. Visit our event page to register for our events and learn more 🔗 https://t.co/daV1AYxJB4

[Brandon Rapier @bsrapier]

https://t.co/MLl2DaAl9P

[Illumina @illumina]

The insight ecosystem is here. Today on the mainstage at #AGBTGM26, we shared how we are delivering the highest quality insights at the lowest end-to-end cost, with a value that continues to grow over time. Key highlights:

🔸Launch of TruPath™ Genome, unlocking the most comprehensive genome with a stunningly simple workflow

🔸Multiomics breakthroughs, enabling researchers to go beyond the genome    

🔸Increasing power on the NovaSeq X through scale, speed, accuracy, and flexibility

If you missed us at #AGBTGM26, register here to see the replay: https://t.co/aCqjQQWCnP

[Illumina @illumina]

In our Gold Sponsor Workshop at #AGBTGM26, we’ll share how we’re reimagining the genome and supporting the next era of biological discovery. Follow this #thread for the latest @illumina innovation, a product launch, and research powered by our multiomics solutions. (1/11)

[Illumina @illumina]

Today we reveal a groundbreaking roadmap of updates for the NovaSeq X, with advances in output, quality, speed, and flexibility.

Our customers are tackling increasingly ambitious projects, and we’re by their side — innovating to take them further. These advancements will unlock the next wave of breakthroughs in human health, while continuing to bring the gold standard in sequencing to new heights.

Learn more about how we are delivering even greater value for our NovaSeq X customers: https://t.co/7kR9wY9aTd

[Brandon Rapier @bsrapier]

Illumina today unveiled an 18-month innovation roadmap for the NovaSeq X system. Updates include a Q70 quality score for the first time, along with 30% increased speed and output up to 35 billion reads (35B). Staggered starts and new flow cells will go live in the near future.

[Illumina @illumina]

Today is the International Day of Women and Girls in Science. Meet Louise Fraser, associate director in assay R&D in the UK. Learn how she began her nearly 20-year career at Illumina, and how she leads a team of scientists unlocking the most challenging regions of the genome 🧬 #EveryVoiceInScience
https://t.co/hWpuJISuDl

[Brandon Rapier @bsrapier]

Illumina webinar: Introduction to MiSq i100 Series
When: Jan 28th 1-2pm EST (virtual)

This Tech Support webinar will provide a comprehensive overview of the MiSeq i100 Series, covering the overall system workflow, analytical applications, and performance.
https://t.co/FgjGpJF3bo

[Illumina @illumina]

At Illumina, we know that together, we can create a sustainable future. Tackling global challenges like food insecurity and conservation requires collaboration across communities. That’s why we’ve created innovative genomic solutions that support researchers and farmers worldwide to develop more productive and sustainable practices.

This weekend, we are at the Plant & Animal Genome Conference #PAG33. Come visit us at booth 303 and see how our microarray and NGS solutions empower researchers to advance sustainable agriculture, reduce food insecurity, and support species conservation and protect biodiversity. @PAGmeeting

Learn more about how we are transforming the future of agriculture: https://t.co/n4Hyuj9voT

[Illumina @illumina]

With the Illumina 5-base solution, researchers are uncovering insights that weren't visible before. ​

Deepen your understanding of disease with combined genomic variant detection and methylation analysis in one workflow.​

What will you uncover with the power of the Illumina 5-base solution? https://t.co/8l1lbeFBiR

[Brandon Rapier @bsrapier]

@illumina will be at the @scientistforum vendor show today from 11:30am - 1:30pm at Purdue Drug Discovery Center. I'll be showcasing our newest multiomics innovations. Come by for a visit.

[Illumina @illumina]

Genomes, exomes, transcriptomes, metabolomes, epigenomes, and now, next-generation proteomics.​

Génome Québec is generating this multiomic data and more on one single platform: NovaSeq X.​

See how NovaSeq X helps you do more: https://t.co/oQMZbMdFtX

[Brandon Rapier @bsrapier]

Join Illumina and Miltenyi for a webinar exploring how single-cell RNA sequencing can accelerate discovery in complex biology and disease. This webinar will walk you through the entire workflow—from upstream sample preparation to downstream data analysis.
https://t.co/Mv0tXpj9h2

[Nicole Renke @NicoleRenke]

1 WEEK LEFT to submit a research proposal for this epigenetics grant. 1,000 free samples-worth of arrays is the prize (aka an extremely well-powered EWAS!)

https://t.co/Tqlg7R0x05 #epigenetics

[Brandon Rapier @bsrapier]

Our Illumina team had the pleasure of hosting Zoetis's 'Precision Animal Health' group in San Diego last week. The pioneering work they are doing in the companion animal and livestock genetic testing spaces is truely impressive. Looking forward what the next 10 years brings!

[Brandon Rapier @bsrapier]

https://t.co/TOpG6ko5Ee

[Brandon Rapier @bsrapier]

NEW Illumina webinar on May 29th (noon EST):

https://t.co/OkQzuSNt2X